Adi Mor
Chief Executive Officer at CHEMOMAB THERAPEUTICS LTD.
Net worth: 18 723 $ as of 2024-04-29
Adi Mor active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Director/Board Member | 2011-09-21 | - |
| Chief Executive Officer | 2023-05-31 | - | |
| Chief Tech/Sci/R&D Officer | 2011-09-21 | - | |
| Founder | 2011-09-21 | - | |
Chemomab Ltd.
 Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Director/Board Member | 2010-12-31 | - |
| Chief Executive Officer | 2010-12-31 | - | |
| Chief Tech/Sci/R&D Officer | 2010-12-31 | - | |
| Founder | 2010-12-31 | - |
Career history of Adi Mor
Training of Adi Mor
| Tel-Aviv University | Doctorate Degree |
Statistics
International
| Israel | 3 |
| 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Chemomab Ltd.
Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Health Technology |
| Chemomab Therapeutics Ltd. |
- Stock Market
- Insiders
- Adi Mor
- Experience
